Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study
Mattson, K, Abratt, R, Ten, G.Velde, Krofta, K, Tonelli, D, Avril, IVolume:
34
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(01)00389-0
Date:
December, 2001
File:
PDF, 115 KB
english, 2001